GO:1901382 regulation of chorionic trophoblast cell proliferation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901382 describes any process that modulates the frequency, rate or extent of chorionic trophoblast cell proliferation, a critical step in placental development.
• Chorionic trophoblast proliferation is regulated by growth factors, oxygen tension, glucose availability, and osmotic stress, with mTOR and cell-cycle checkpoints as central nodes.
• Dysregulated trophoblast proliferation is linked to fetal growth restriction, recurrent miscarriage, and preeclampsia.
• Key genes include PFKFB2, PRDX2, eIF5A, and SNORD88B, which influence proliferation, apoptosis, and invasion.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of these regulatory pathways.
• EDITGENE provides end-to-end CRISPR services, from library screening to bioinformatics, to accelerate trophoblast research.
Description
The Gene Ontology term GO:1901382, regulation of chorionic trophoblast cell proliferation, defines any process that modulates the frequency, rate or extent of proliferation of chorionic trophoblast cells. Chorionic trophoblast cells are the epithelial cells of the placenta that form the interface between maternal and fetal circulations, and their controlled proliferation is essential for normal placental development and fetal growth. Disruption of this regulation is associated with major pregnancy complications, including fetal growth restriction, recurrent miscarriage, and preeclampsia. Understanding the molecular players that govern trophoblast proliferation is therefore a high-priority area in reproductive biology and medicine. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:1901382, covering its definition, mechanisms, key genes, disease links, and experimental models. Researchers can use this resource to design CRISPR-based studies that test causal roles of candidate regulators in trophoblast proliferation.
regulation of chorionic trophoblast cell proliferation At A Glance
| GO ID | GO:1901382 |
|---|---|
| GO term | regulation of chorionic trophoblast cell proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of chorionic trophoblast cell proliferation |
| Related processes | Trophoblast invasion, placental development, fetal growth |
| Key signaling nodes | mTOR, cell cycle checkpoints, glucose and osmotic stress responses |
| Disease relevance | Fetal growth restriction, recurrent miscarriage, preeclampsia |
What Is GO:1901382?
GO:1901382 is a biological process term that encompasses any molecular event or pathway that changes the frequency, rate, or extent of chorionic trophoblast cell proliferation. In other words, it is the regulatory layer that controls how often and how rapidly these placental cells divide, rather than the proliferation process itself. This regulation can be positive or negative and is mediated by extracellular signals, intracellular signaling cascades, cell-cycle machinery, and metabolic cues.
Why Is regulation of chorionic trophoblast cell proliferation Important in Cell Biology?
Regulation of chorionic trophoblast cell proliferation is fundamental to placental function and fetal health. The trophoblast is the first lineage to differentiate during embryogenesis and is responsible for implantation, nutrient exchange, and hormone production. When proliferation is dysregulated, the placenta may fail to develop adequately, leading to fetal growth restriction, miscarriage, or hypertensive disorders of pregnancy. Moreover, trophoblast proliferation shares molecular features with cancer cell proliferation, making it a useful model for understanding both normal and pathological cell-cycle control. Thus, studying GO:1901382 has broad implications for reproductive medicine, developmental biology, and cancer research.
• Essential for normal placental development and fetal growth.
• Dysregulation causes fetal growth restriction and recurrent miscarriage.
• Involved in pregnancy complications such as preeclampsia.
• Shares signaling pathways with cancer proliferation, offering translational insights.
• Glucose and osmotic stress directly impact trophoblast proliferation.
• mTOR/PGC-1α pathway links metabolism to trophoblast survival.
• Non-coding RNAs (e.g., SNORD88B, circ_0008440) regulate trophoblast proliferation.
• eIF5A is required for trophoblast function and proliferation.
• PRDX2 downregulation impairs proliferation and increases apoptosis.
• Provides targets for therapeutic intervention in pregnancy disorders.
What Happens During regulation of chorionic trophoblast cell proliferation?
Extracellular signal sensing
In simple terms: Cells first detect signals from their environment that tell them whether to divide.
Chorionic trophoblast cells respond to growth factors, hormones, oxygen levels, glucose concentration, and osmotic pressure. For example, glucose and osmotic pressure directly influence the proliferation and cell cycle progression of human chorionic trophoblast cells. These environmental cues are integrated by membrane receptors and intracellular sensors, initiating signaling cascades that either promote or inhibit proliferation.
Intracellular signaling cascades
In simple terms: Signals are relayed inside the cell through a series of molecular switches.
Key pathways include the mTOR/PGC-1α axis, which regulates metabolism and survival; its inhibition leads to anti-proliferation and apoptosis in trophoblast cells. Other pathways involve eukaryotic initiation factor 5A (eIF5A), which supports trophoblast function, and non-coding RNAs such as SNORD88B that modulate m6A modification and alternative splicing of G3BP1 to promote proliferation. These cascades converge on cell-cycle regulators.
Cell cycle checkpoint control
In simple terms: The cell decides whether to commit to division by passing through checkpoints.
Progression through the cell cycle is governed by cyclins, cyclin-dependent kinases, and checkpoint proteins. Glucose and osmotic stress alter the expression of cell cycle regulators, affecting the G1/S transition and proliferation rate. Dysregulation of these checkpoints can lead to either excessive proliferation or cell cycle arrest and apoptosis, as seen in miscarriage-associated trophoblast cells.
Apoptosis and survival balance
In simple terms: The cell weighs survival signals against death signals.
Regulation of proliferation is tightly coupled to apoptosis. For instance, downregulation of peroxiredoxin 2 (PRDX2) reduces proliferation and increases apoptosis in trophoblast cells, contributing to recurrent miscarriage. Similarly, circ_0008440 inhibits proliferation and promotes apoptosis through the miR-194-5p/PFKFB2 axis. Thus, the balance between pro-survival and pro-apoptotic signals determines net proliferative output.
Integration with invasion and differentiation
In simple terms: Proliferation is coordinated with other cell behaviors like movement and specialization.
Trophoblast proliferation is not isolated; it is coordinated with invasion and differentiation. SNORD88B promotes both proliferation and invasion of trophoblast cells, while eIF5A is involved in multiple trophoblast functions. This integration ensures proper placental architecture and function.
Key Genes Involved in GO:1901382 regulation of chorionic trophoblast cell proliferation
The following genes and proteins have been experimentally implicated in the regulation of chorionic trophoblast cell proliferation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PFKFB2 | Glycolytic enzyme; regulated by circ_0008440/miR-194-5p | Inhibition reduces proliferation and promotes apoptosis |
| PRDX2 | Antioxidant enzyme; protects against oxidative stress | Downregulation impairs proliferation and increases apoptosis in recurrent miscarriage |
| eIF5A | Translation elongation factor; supports cell survival | Involved in trophoblast function and proliferation |
| SNORD88B | Small nucleolar RNA; regulates m6A modification and splicing | Promotes proliferation and invasion via G3BP1 |
| G3BP1 | RNA-binding protein; stress granule component | Target of SNORD88B-mediated m6A modification |
| mTOR | Serine/threonine kinase; central growth regulator | Inhibition leads to anti-proliferation and apoptosis via PGC-1α |
| PGC-1α | Transcriptional coactivator; mitochondrial biogenesis | Mediates mTOR effects on trophoblast survival |
| Circ_0008440 | Circular RNA; sponge for miR-194-5p | Inhibits proliferation and promotes apoptosis |
| miR-194-5p | MicroRNA; targets PFKFB2 | Mediates circ_0008440 effects on proliferation |
| Cyclins (e.g., cyclin D1) | Cell cycle regulators | Modulated by glucose and osmotic stress |
| CDKs (e.g., CDK4/6) | Cell cycle kinases | Control G1/S transition in trophoblast |
| VEGF | Growth factor; promotes angiogenesis and proliferation | Supports trophoblast proliferation (implied in) |
| EGF | Growth factor; stimulates proliferation | Regulates trophoblast growth (implied in) |
| IGF-II | Growth factor; promotes proliferation | Involved in placental growth (implied in) |
| HIF-1α | Hypoxia-inducible factor; responds to oxygen tension | Regulates trophoblast proliferation under hypoxia (implied in) |
How Is regulation of chorionic trophoblast cell proliferation Regulated?
The regulation of chorionic trophoblast cell proliferation is orchestrated by a network of signaling pathways. The mTOR/PGC-1α pathway is a central regulator; its inhibition reduces proliferation and induces apoptosis in trophoblast cells of miscarriage. Glucose availability and osmotic pressure directly modulate cell cycle progression and proliferation. Non-coding RNAs, such as SNORD88B and circ_0008440, fine-tune proliferation by affecting mRNA modification, splicing, and miRNA sponging. Additionally, eIF5A supports trophoblast function and proliferation, while PRDX2 protects against oxidative stress-induced inhibition of proliferation. These pathways are integrated with oxygen sensing and growth factor signaling to ensure proper placental development.
regulation of chorionic trophoblast cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRDX2 | Recurrent miscarriage | Knockout or knockdown in HTR-8/SVneo cells |
| PFKFB2 | Miscarriage, apoptosis | Overexpression or knockout in trophoblast cell lines |
| mTOR | Miscarriage, FGR | Point mutation or knockout in primary trophoblast |
| SNORD88B | Placental development | Knock-in or knockout in JEG-3 cells |
| eIF5A | Trophoblast dysfunction | Knockdown or overexpression in HTR-8/SVneo |
Fetal growth restriction (FGR)
Fetal growth restriction is often caused by placental insufficiency, where impaired trophoblast proliferation and invasion lead to reduced nutrient and oxygen transport. Pathophysiology of placental-derived FGR involves abnormal trophoblast turnover and vascular development. Studying GO:1901382 helps identify molecular drivers of FGR.
Recurrent miscarriage
Recurrent miscarriage is associated with decreased trophoblast proliferation and increased apoptosis. Downregulation of PRDX2 impairs proliferation and promotes apoptosis in trophoblast cells, contributing to miscarriage. Similarly, inhibition of the mTOR/PGC-1α pathway induces anti-proliferation and apoptosis in miscarriage-derived trophoblast cells.
Preeclampsia
Preeclampsia is characterized by abnormal trophoblast invasion and proliferation, leading to placental ischemia. Although not directly cited in the provided references, the role of trophoblast proliferation in preeclampsia is well established and linked to FGR pathophysiology.
Cancer parallels
Trophoblast proliferation shares molecular features with cancer, including reliance on mTOR signaling and evasion of apoptosis. The mTOR/PGC-1α pathway in trophoblast cells mirrors cancer cell metabolism, offering a model for studying proliferation control.
From regulation of chorionic trophoblast cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate trophoblast proliferation? | CRISPR knockout in HTR-8/SVneo or JEG-3 cells |
| Does a specific mutation in gene X affect proliferation? | Point mutation knock-in via CRISPR in trophoblast cell lines |
| Does overexpression of gene X enhance proliferation? | CRISPR activation or lentiviral overexpression |
| Does gene X interact with pathway Y? | Tagged knock-in for co-IP or proximity labeling |
| Does gene X affect cell cycle progression? | Knockout combined with flow cytometry |
| Does gene X influence apoptosis? | Knockout with Annexin V staining |
How to Study the regulation of chorionic trophoblast cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU incorporation | DNA synthesis (S phase) | Proliferation rate in trophoblast cells |
| MTT assay | Metabolic activity | Cell viability and proliferation |
| Flow cytometry | Cell cycle distribution | G1/S transition analysis |
| Annexin V/PI staining | Apoptosis | Cell death assessment |
| Western blot | Protein expression | Validation of pathway changes |
| qRT-PCR | mRNA expression | Gene expression profiling |
| RNA-seq | Transcriptome-wide expression | Discovery of novel regulators |
| Immunofluorescence | Protein localization | Tissue architecture and marker expression |
Cell proliferation assays
Common methods include EdU incorporation, MTT, and colony formation assays to measure proliferation rates. These are used to assess the effects of gene knockout or overexpression on trophoblast proliferation.
Cell cycle analysis
Flow cytometry with propidium iodide staining determines cell cycle distribution, revealing G1/S or G2/M arrest. This is critical for understanding how regulators like glucose or osmotic stress affect proliferation.
Apoptosis assays
Annexin V/PI staining and caspase activity assays quantify apoptosis. These are used to study the balance between proliferation and death in trophoblast cells.
RNA sequencing and bioinformatics
RNA-seq identifies differentially expressed genes and pathways upon perturbation. Bioinformatics analyses, such as GO enrichment, can highlight regulation of proliferation as a key process.
How CRISPR Can Be Used to Study GO:1901382 regulation of chorionic trophoblast cell proliferation
Knockout
CRISPR knockout of candidate genes in trophoblast cell lines (e.g., HTR-8/SVneo, JEG-3) can determine whether a gene is necessary for proliferation. For example, knocking out PFKFB2 or PRDX2 would test their requirement for proliferation and survival.
Point Mutation
Introducing specific point mutations (e.g., in mTOR or PFKFB2) can dissect phosphorylation sites or catalytic residues that regulate proliferation. This is useful for understanding mechanism.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA) allows visualization and immunoprecipitation of endogenous proteins. This helps study localization and interactions of regulators like eIF5A.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can test sufficiency of a gene to drive proliferation. Overexpressing SNORD88B or circ_0008440 would validate their roles.
How EDITGENE Supports regulation of chorionic trophoblast cell proliferation Research
Researchers studying regulation of chorionic trophoblast cell proliferation-related genes often need to determine whether a candidate gene is causally involved in proliferation, apoptosis, or cell cycle control. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of chorionic trophoblast cell proliferation research.
Frequently Asked Questions About regulation of chorionic trophoblast cell proliferation
What is GO:1901382?
GO:1901382 is the Gene Ontology term for regulation of chorionic trophoblast cell proliferation, describing any process that modulates the frequency, rate or extent of proliferation of chorionic trophoblast cells.
What genes are involved in regulation of chorionic trophoblast cell proliferation?
Key genes include PFKFB2, PRDX2, eIF5A, SNORD88B, G3BP1, mTOR, and PGC-1α, among others.
How is chorionic trophoblast cell proliferation regulated?
It is regulated by growth factors, glucose and osmotic stress, mTOR signaling, non-coding RNAs, and cell cycle checkpoints.
Why is trophoblast proliferation important in pregnancy?
Proper trophoblast proliferation ensures placental development and fetal growth; dysregulation leads to miscarriage, fetal growth restriction, and preeclampsia.
What diseases are associated with abnormal trophoblast proliferation?
Fetal growth restriction, recurrent miscarriage, and preeclampsia are major associated diseases.
How can CRISPR be used to study trophoblast proliferation?
CRISPR knockout, point mutation, knock-in, and overexpression can test causal roles of genes in trophoblast proliferation.
What cell lines are used to study chorionic trophoblast proliferation?
HTR-8/SVneo and JEG-3 are commonly used human trophoblast cell lines.
What signaling pathways regulate trophoblast proliferation?
The mTOR/PGC-1α pathway, glucose metabolism, and non-coding RNA networks are key regulators.
How does glucose affect trophoblast proliferation?
Glucose and osmotic pressure directly influence proliferation and cell cycle progression of human chorionic trophoblast cells.
What is the role of PRDX2 in trophoblast proliferation?
PRDX2 downregulation reduces proliferation and increases apoptosis, contributing to recurrent miscarriage.
Conclusion
GO:1901382, regulation of chorionic trophoblast cell proliferation, is a critical biological process for placental development and fetal health. Its dysregulation is implicated in major pregnancy complications, and the underlying molecular mechanisms involve mTOR signaling, metabolic cues, non-coding RNAs, and cell cycle control. CRISPR-based models offer powerful tools to dissect these pathways and identify therapeutic targets. EDITGENE's comprehensive services support researchers in advancing this field.
References
- 1. Burton GJ et al.. 2018. Pathophysiology of placental-derived fetal growth restriction.. Am J Obstet Gynecol 218(2S):S745-S761 PMID: 29422210
- 2. Wang Z et al.. 2022. Effects of glucose and osmotic pressure on the proliferation and cell cycle of human chorionic trophoblast cells.. Open Life Sci 17(1):1418-1428 PMID: 36448057
- 3. Lu B et al.. 2025. SNORD88B promotes proliferation and invasion of trophoblast by regulating G3BP1 m6 A modification and alternative splicing.. Cell Mol Life Sci 82(1):225 PMID: 40471366
- 4. Qin X et al.. 2020. The involvement of eukaryotic initiation factor 5A in trophoblast cell function.. Reproduction 159(2):205-214 PMID: 31829975
- 5. Guo L et al.. 2025. Circ_0008440 Inhibits Proliferation and Promotes Apoptosis of Trophoblast Cells through the miR-194-5p/PFKFB2 Axis.. Reprod Sci 32(5):1600-1611 PMID: 39663300
- 6. Aplin JD. 2010. Developmental cell biology of human villous trophoblast: current research problems.. Int J Dev Biol 54(2-3):323-9 PMID: 19876840
- 7. Wu F et al.. 2017. Role of peroxiredoxin2 downregulation in recurrent miscarriage through regulation of trophoblast proliferation and apoptosis.. Cell Death Dis 8(6):e2908 PMID: 28661480
- 8. Zhu Y et al.. 2024. Anti-proliferation and apoptosis induced via the mTOR/PGC-1α signaling pathway in trophoblast cells of miscarriage.. Exp Cell Res 436(2):113959 PMID: 38395376
